Truvada Patients That Stop Taking The Drug Could Allow The Virus To Build Up in Their Blood Making it More Difficult To Treat in The Future urges its Truvada patients to seek medical attention before altering their daily Truvada regimen

Truvada Bone Lawsuit News

Wednesday, May 13, 2020 - There is a potentially life-threatening trend occurring for patients that are taking HIV treatment drug Truvada. On the one hand, millions of HIV positive individuals take Truvada to mitigate the symptoms of the AIDS virus and to stop or slow its progression and also million of HIV negative people take the drug as a prophylactic medication to prevent the spread of the disease from one sexual partner to another. Unfortunately, patients in both camps are discontinuing taking their Truvada drug without first seeking the advice of their physician because they are afraid of contracting COVID19 and being unable to fight off the virus due to their weakened immune system. Scientists concerned with helping HIV positive patients deal with their disease are reporting that an alarmingly high percentage of patients surveyed may have temporarily discontinued taking the drug until the current pandemic has blown over. Others taking Truvada to treat their existing condition continue to take the anti-viral drug cocktail in the hope the drug will help prevent them from getting COVID19. Experts caution, however, that neither approach is scientifically sound as Truvada builds up in one's cells and has to reach a certain level to be effective. Failing to take Truvada every day could be as bad as not taking the drug at all allowing the disease to progress or giving others false hope of being protected during sexual activity. Truvada attorneys offer a free consultation with no obligation to file a claim and are helping people suffering from side effects such as brittle, broken bones and kidney failure from taking Truvada. describes the basic function of Truvada in mitigating the progression of AIDS. "Emtricitabine and tenofovir disoproxil fumarate are antiviral medicines that prevent human immunodeficiency virus (HIV) from multiplying in your body. Emtricitabine and tenofovir is to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS)." offers definitive guidance on what to do regarding taking the drug during the pandemic and emplores their patients to continue taking the drug and to make sure that they do not run out. "It's important that you take TRUVADA exactly as your healthcare provider prescribed it. Do not change your dose or stop taking TRUVADA without first talking with your healthcare provider. The usual dose of TRUVADA is one tablet once a day. TRUVADA is always used together with other HIV-1 medicines to help treat HIV-1. If you have kidney problems, you may need to take TRUVADA less often," according to The company also warns that HIV positive patients must continue to take the drug every day because to stop taking the drug even temporarily may cause the amount of the AIDS virus in one's blood to increase, develop a resistance to Truvada and become harder to treat.

Despite Truvada being a proven effective medication in treating AIDS patients as well as preventing the transmission of the disease, the drug carries the serious and potentially life-threatening side effects of having caused, kidney failure, adverse changes in the immune system, bone density problems that have led to leg fractures in patients, excess acid in the blood, and severe liver problems. Individuals with pre-existing conditions should consider these and other potential side effects before committing to taking Truvada.

More Recent Truvada Bone Lawsuit News:

No-Cost, No-Obligation Truvada Lawsuit Case Review If You or a Loved One Suffered from Truvada Bone or Kidney Complications

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.